首页> 美国卫生研究院文献>Infection and Immunity >Evaluation of Fab and F(ab′)2 Fragments and Isotype Variants of a Recombinant Human Monoclonal Antibody against Shiga Toxin 2
【2h】

Evaluation of Fab and F(ab′)2 Fragments and Isotype Variants of a Recombinant Human Monoclonal Antibody against Shiga Toxin 2

机译:重组人志贺毒素2单克隆抗体的Fab和F(ab)2片段和同种型变异体的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

5C12 HuMAb is a human monoclonal antibody against the A subunit of Shiga toxin 2 (Stx2). We have previously shown that 5C12 HuMAb effectively neutralizes the cytotoxic effects of this toxin by redirecting its transport within the cell and also by neutralizing the toxin's ability to inhibit protein synthesis. The 5C12 HuMAb and its recombinant IgG1 version protect mice at a dose of 0.6 μg against a lethal challenge of Stx2. The contribution of the Fc region to this observed neutralization activity of the 5C12 antibody against Stx2 was investigated in this study. Using recombinant DNA technology, 5C12 isotype variants (IgG1, IgG2, IgG3, and IgG4) and antibody fragments [Fab, F(ab′)2] were expressed in Chinese hamster ovary cells and evaluated in vitro and in vivo. All four 5C12 isotype variants showed protection in vitro, with the IgG3 and IgG4 variants showing the highest protection in vivo. The Fab and F(ab′)2 fragments also showed protection in vitro but no protection in the mouse toxicity model. Similar results were obtained for a second HuMAb (5H8) against the B subunit of Stx2. The data suggest the importance of the Fc region for neutralization activity, but it is not clear if this is related to the stability of the full-length antibody or if the Fc region is required for effective elimination of the toxin from the body.
机译:5C12 HuMAb是针对志贺毒素2(Stx2)A亚基的人单克隆抗体。先前我们已经表明5C12 HuMAb通过改变其在细胞内的运输方向以及中和该毒素抑制蛋白质合成的能力来有效中和该毒素的细胞毒性作用。 5C12 HuMAb及其重组IgG1版本以0.6μg的剂量保护小鼠免受Stx2的致命攻击。在这项研究中,研究了Fc区对该5C12抗体针对Stx2的中和活性的贡献。使用重组DNA技术,在中国仓鼠卵巢细胞中表达了5C12同种型变体(IgG1,IgG2,IgG3和IgG4)和抗体片段[Fab,F(ab')2],并在体内和体外进行了评估。所有四个5C12同种型变体均显示出体外保护,其中IgG3和IgG4变体显示出最高的体内保护。 Fab和F(ab')2片段在体外也显示出保护作用,但在小鼠毒性模型中没有显示出保护作用。针对Stx2的B亚基的第二个HuMAb(5H8)获得了相似的结果。数据表明Fc区对于中和活性的重要性,但是尚不清楚这是否与全长抗体的稳定性有关,或者是否需要Fc区从体内有效清除毒素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号